leucine has been researched along with Thymoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anzai, N; Chida, M; Endou, H; Fujita, T; Hayashi, K; Jutabha, P; Maeda, S; Ouchi, M; Supak, Y | 1 |
| Auger, R; Kanellopoulos, J; Le Stunff, H; Raymond, MN | 1 |
| Azcona-Olivera, JI; Brooks, KH; Dong, W; Linz, JE; Pestka, JJ | 1 |
3 other study(ies) available for leucine and Thymoma
| Article | Year |
|---|---|
LAT1 acts as a crucial transporter of amino acids in human thymic carcinoma cells.
Topics: Amino Acids; Benzoxazoles; Cell Line, Tumor; Humans; Large Neutral Amino Acid-Transporter 1; Leucine; Thymoma; Thymus Neoplasms; Tyrosine | 2016 |
The Pro-451 to Leu polymorphism within the C-terminal tail of P2X7 receptor impairs cell death but not phospholipase D activation in murine thymocytes.
Topics: Adenosine Triphosphate; Animals; Annexin A5; Cell Membrane; DNA Fragmentation; Dose-Response Relationship, Drug; Enzyme Activation; Flow Cytometry; In Situ Nick-End Labeling; L-Lactate Dehydrogenase; Leucine; Ligands; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Phospholipase D; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Proline; Protein Structure, Tertiary; Pyridoxal Phosphate; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Thymoma; Thymus Gland; Time Factors | 2004 |
Elevated gene expression and production of interleukins 2, 4, 5, and 6 during exposure to vomitoxin (deoxynivalenol) and cycloheximide in the EL-4 thymoma.
Topics: Clone Cells; Cycloheximide; Cytokines; Gene Expression; Interleukins; Kinetics; Leucine; Models, Biological; RNA, Messenger; Stimulation, Chemical; T-Lymphocytes; Tetradecanoylphorbol Acetate; Thymoma; Thymus Neoplasms; Trichothecenes; Tritium; Tumor Cells, Cultured | 1994 |